NYSE:TDOC Stock Quote
8.0850
-0.4750 (-5.55%)
Teladoc Health is a leading telehealth company that provides virtual healthcare services, connecting patients with a wide range of healthcare professionals through digital platforms
The company offers various services, including remote consultations, mental health support, chronic condition management, and preventive care. By leveraging technology, Teladoc facilitates access to healthcare for individuals regardless of their location, aiming to improve health outcomes and enhance the patient experience. Their comprehensive solutions cater to both individual consumers and large employers, helping to make healthcare more accessible and efficient.
Previous Close | 8.560 |
---|---|
Open | 8.500 |
Bid | 8.080 |
Ask | 8.090 |
Day's Range | 8.065 - 8.510 |
52 Week Range | 6.760 - 15.28 |
Volume | 3,492,256 |
Market Cap | 1.32B |
PE Ratio (TTM) | -1.380 |
EPS (TTM) | -5.9 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 7,402,019 |
News & Press Releases
The healthcare industry stands on the brink of a transformative decade, driven by rapid advancements in technology, shifting demographics, and evolving patient expectations. Over the next ten years, we will witness groundbreaking changes that redefine how care is delivered, diseases are treated, and wellness is maintained. Below, we explore ten
Via MarketMinute · March 27, 2025
Teladoc has been treading water for the past six months, recording a small return of 2.5% while holding steady at $8.62.
Via StockStory · March 26, 2025
Let’s dig into the relative performance of Sea (NYSE:SE) and its peers as we unravel the now-completed Q3 online marketplace earnings season.
Via StockStory · March 26, 2025
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NYSE:TDOC),(NASDAQ:TALK),(NASDAQ:BFRG) EQNX::TICKER_END
Via FinancialNewsMedia · March 25, 2025
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how eHealth (NASDAQ:EHTH) and the rest of the online marketplace stocks fared in Q4.
Via StockStory · March 25, 2025
PALM BEACH, Fla., March 25, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Artificial intelligence (AI) has become a significant part of healthcare and is being used in almost all sectors, including diagnostics. The integration of AI has increased the growth and development of the healthcare industry. In diagnostic testing, AI is used to analyze medical images (CT scans, X-rays, ultrasounds, MRIs, and DXAs), large patient data, vital signs (pulse rate, body temperature, blood pressure, and respiration rate), medical history, and laboratory test results. AI provides several advantages in diagnostics, such as accuracy, efficiency, reduced human errors, and cost savings. Healthcare professionals can make more informed decisions and develop personalized treatment options. The AI in the diagnostics market is growing due to reduced healthcare costs, reduced healthcare burden on professionals, and enhanced patient satisfaction. A recent report from Towards Healthcare, said: “The global AI in diagnostics market is to value at US$ 1.74 billion in 2025 is to touch US$ 5.24 billion by 2030. In 2023, North America led the AI in diagnostics market with a 53% share, while Asia Pacific is set to experience the fastest growth. The software segment dominated by component and is expected to show the highest CAGR. In diagnosis, neurology held the largest market share, while radiology is predicted to grow at the quickest pace during the forecast period. AI in diagnostics is advancing accuracy and efficiency in medical evaluations, driving its global expansion across various sectors.” Active healthcare/tech companies active in the markets include: Avant Technologies Inc. (OTCQB: AVAI), Tempus AI, Inc. (NASDAQ: TEM), Teladoc Health (NYSE: TDOC), Talkspace (NASDAQ: TALK), BullFrog AI Holdings, Inc. (NASDAQ: BFRG).
By FN Media Group LLC · Via GlobeNewswire · March 25, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how online marketplace stocks fared in Q4, starting with Etsy (NASDAQ:ETSY).
Via StockStory · March 24, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how online marketplace stocks fared in Q4, starting with Teladoc (NYSE:TDOC).
Via StockStory · March 18, 2025
Teladoc Health (TDOC) under pressure after Q4 earnings, JPMorgan analyst Lisa Gill reaffirms neutral rating, price target $11. Revenue estimate of $617.5 million for Q1.
Via Benzinga · March 17, 2025
Via The Motley Fool · March 17, 2025
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at online marketplace stocks, starting with Shutterstock (NYSE:SSTK).
Via StockStory · March 13, 2025

The integration enables seamless referrals for GI Care through Teladoc Health’s platform
By Cylinder Health · Via GlobeNewswire · March 12, 2025

New digital health partners in specialty care, digestive health, fertility, and family building available for Teladoc Health care team referral on the company’s Prism care platform
By Teladoc Health, Inc. · Via GlobeNewswire · March 11, 2025

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the online marketplace stocks, including The RealReal (NASDAQ:REAL) and its peers.
Via StockStory · March 11, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at MercadoLibre (NASDAQ:MELI) and the best and worst performers in the online marketplace industry.
Via StockStory · March 11, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at EverQuote (NASDAQ:EVER) and its peers.
Via StockStory · March 10, 2025

Via FinancialNewsMedia · March 10, 2025

PALM BEACH, Fla., March 10, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - A report from Fortune Business Insights said that the global artificial intelligence in healthcare market size is projected to grow from USD 27.69 billion in 2024 to USD 490.96 billion by 2032, exhibiting a CAGR of 43.2% during the forecast period. The report added: “AI in healthcare market in the U.S. is experiencing rapid expansion, driven by the increasing adoption of AI-powered solutions for diagnostics, personalized treatment, and administrative automation. North America dominated the AI in the healthcare market with a market share of 44.93% in 2023. Artificial Intelligence in healthcare is used to analyze the medical data that helps doctors and medical providers deliver accurate diagnoses and treatments to their patients. AI in healthcare assists doctors, nurses, and other healthcare workers to enhance their productivity. This advancement helps patients in treatment and improves their quality of life. Also, according to an article published by GE Healthcare, it is found that healthcare professionals are already using AI to improve data analysis, which has enabled them to diagnose their patients in a better way with proper predictions for the treatment and decrease the time spent by the medical staff on administrative functioning.” Active companies active in the healthcare markets include: Avant Technologies Inc. (OTCQB: AVAI), Tempus AI, Inc. (NASDAQ: TEM), Teladoc Health (NYSE: TDOC), Aclarion, Inc. (NASDAQ: ACON), Medtronic plc (NYSE:MDT).
By FN Media Group LLC · Via GlobeNewswire · March 10, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings.
However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Via StockStory · March 7, 2025

Teladoc Health is integrating LillyDirect into its Chronic Care Weight Management program, potentially boosting enrollments.
Via Benzinga · March 7, 2025

Teladoc Health teams up with Eli Lilly's LillyDirect to improve Zepbound access, offering direct home delivery and comprehensive obesity care support.
Via Benzinga · March 6, 2025

Pharmacy Integration with Gifthealth to Extend Seamless Support for FDA-Approved Medication to Obesity Program Members Without GLP-1 Coverage
By Teladoc Health, Inc. · Via GlobeNewswire · March 6, 2025

PURCHASE, NY, March 05, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to 21 new employees.
By Teladoc Health, Inc. · Via GlobeNewswire · March 5, 2025

New enhancements to the company’s Prism care delivery platform connect and assist digital and in-person care teams in coordinating care and driving positive health outcomes
By Teladoc Health, Inc. · Via GlobeNewswire · March 4, 2025